Volume 69 Received 20 December 2012 | ||||||||||
| ||||||||||
aSchool of Physics, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia
Correspondence e-mail: arazaki@usm.my
The asymmetric unit of the title compound, 2C10H11N2+·2C3H3O4-·C3H4O4, consists of one 5-amino-6-methylquinolin-1-ium cation, one hydrogen malonate (2-carboxyacetate) anion and one-half molecule of malonic acid which lies on a twofold rotation axis. The quinoline ring system is essentially planar, with a maximum deviation of 0.062 (2) Å for all non-H atoms. In the anion, an intramolecular O-H
O hydrogen bond generates an S(6) ring. In the crystal, the components are linked via N-H
O and O-H
O hydrogen bonds into layers parallel to the ac plane. The crystal structure also features weak C-H
O hydrogen bonds and a
-
stacking interaction with a centroid-centroid distance of 3.8189 (10) Å.
For background to and the biological activity of quinoline derivatives, see: Sasaki et al. (1998
); Reux et al. (2009
); Morimoto et al. (1991
); Markees et al. (1970
). For related structures, see: Thanigaimani et al. (2013a
,b
); Loh et al. (2010
). For hydrogen-bond motifs, see: Bernstein et al. (1995
). For bond-length data, see: Allen et al. (1987
).
|
|
|
Data collection: APEX2 (Bruker, 2009
); cell refinement: SAINT (Bruker, 2009
); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008
); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: IS5233 ).
The authors thank the Malaysian Government and Universiti Sains Malaysia (USM) for the research facilities and USM Short Term Grant No. 304/PFIZIK/6312078 to conduct this work. KT thanks The Academy of Sciences for the Developing World and USM for a TWAS-USM fellowship.
Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.
![[ISI]](../../../../../../logos/isiborder.gif)
Bruker (2009). SADABS, APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Loh, W.-S., Quah, C. K., Hemamalini, M. & Fun, H.-K. (2010). Acta Cryst. E66, o2357.
![[details]](../../../../../../e/graphics/details.gif)
Markees, D. G., Dewey, V. C. & Kidder, G. W. (1970). J. Med. Chem. 13, 324-326.
![[ISI]](../../../../../../logos/isiborder.gif)
Morimoto, Y., Matsuda, F. & Shirahama, H. (1991). Synlett, 3, 202-203. ![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Reux, B., Nevalainen, T., Raitio, K. H. & Koskinen, A. M. P. (2009). Bioorg. Med. Chem. 17, 4441-4447.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Sasaki, K., Tsurumori, A. & Hirota, T. (1998). J. Chem. Soc. Perkin Trans. 1, pp. 3851-3856. ![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Thanigaimani, K., Khalib, N. C., Arshad, S. & Razak, I. A. (2013a). Acta Cryst. E69, o42-o43.
![[details]](../../../../../../e/graphics/details.gif)
Thanigaimani, K., Khalib, N. C., Arshad, S. & Razak, I. A. (2013b). Acta Cryst. E69, o44.
![[details]](../../../../../../e/graphics/details.gif)